Effects of culling on badger abundance : implications for tuberculosis control

Culling is often considered as a tool for controlling wildlife diseases that can also infect people or livestock. Culling European badgers Meles meles can cause both positive and negative effects on the incidence of bovine tuberculosis (TB) in cattle. One factor likely to influence the outcome of different badger culling strategies for cattle TB is the reduction in badger population density achieved. However, this reduction is difficult to measure because badgers, being nocturnal and fossorial, are difficult to count. Here, we use indices of badger abundance to measure the population impacts of two culling strategies tested in Britain. The densities of badger setts and latrines recorded before culling were correlated with the densities of badgers captured on initial culls, suggesting that both were indices of actual badger abundance. Widespread 'proactive' culling was associated with a 73% reduction in the density of badger latrines, a 69% reduction in the density of active burrows and a 73% reduction in the density of road killed badgers. This population reduction was achieved by a coordinated effort entailing widespread and repeated trapping over several years. However, this strategy caused only modest reductions in cattle TB incidence in culled areas and elevated incidence in neighbouring unculled areas. Localized 'reactive' culling caused a 26% reduction in latrine density, a 32% reduction in active burrow density and a 10% reduction in the density of road killed badgers, but apparently increased the incidence of cattle TB. These results indicate that the relationship between badger population reduction and TB transmission to cattle is strongly non linear, probably because culling prompts changes in badger behaviour that influence transmission rates. These findings raise serious questions about the capacity of badger culling to contribute to the control of cattle TB in Britain

Late Winter Biogeochemical Conditions Under Sea Ice in the Canadian High Arctic

With the Arctic summer sea-ice extent in decline, questions are arising as to how changes in sea-ice dynamics might affect biogeochemical cycling and phenomena such as carbon dioxide (CO2) uptake and ocean acidification. Recent field research in these areas has concentrated on biogeochemical and CO2 measurements during spring, summer or autumn, but there are few data for the winter or winter–spring transition, particularly in the High Arctic. Here, we present carbon and nutrient data within and under sea ice measured during the Catlin Arctic Survey, over 40 days in March and April 2010, off Ellef Ringnes Island (78° 43.11′ N, 104° 47.44′ W) in the Canadian High Arctic. Results show relatively low surface water (1–10 m) nitrate (<1.3 µM) and total inorganic carbon concentrations (mean±SD=2015±5.83 µmol kg−1), total alkalinity (mean±SD=2134±11.09 µmol kg−1) and under-ice pCO2sw (mean±SD=286±17 µatm). These surprisingly low wintertime carbon and nutrient conditions suggest that the outer Canadian Arctic Archipelago region is nitrate-limited on account of sluggish mixing among the multi-year ice regions of the High Arctic, which could temper the potential of widespread under-ice and open-water phytoplankton blooms later in the season

Nucleus gracilis responses to knee joint motion: A frequency response study

1. (1) A systems analysis approach was used to study the dynamic responses of sensory cells in thenucleus gracilis of anesthetized cats. Sinusoidal changes in knee angle were used as inputs and the average firing rate of single gracile cells was recorded as the output. Frequency response functions were derived from data displayed as Bode plots.2. (2) Fifty-nine cells were studied. The majority of these cells exhibited an acceleration sensitivity but 5 cells exhibited a velocity sensitivity. No position sensitivity was evident and no slowly adapting or tonic responses were recorded.3. (3) The acceleration sensitive cells demonstrated significant non-linear responses. The gain associated with their frequency response function depended upon both static knee angle and input excursion amplitude. These cells also exhibited a bi-directional response to sinusoidal and square wave inputs.4. (4) These data are taken as evidence that the dorsal columns may carry acceleration and velocity information from receptors in the knee joint, but that positional information may travel by other pathways to cells located in other areas. If such is the case, lesion experiments involving the dorsal columns should reveal loss of velocity and acceleration sense but no decrement in position sense.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/33751/1/0000003.pd

gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells.

CD4(+) T cells modulate the magnitude and durability of CTL responses in vivo, and may serve as effector cells in the tumour microenvironment. In order to identify the turnout epitopes recognized by tumour-reactive human CD4+ T cells, we combined the use of an HLA-DR4/peptide binding algorithm with an IFN-gamma ELISPOT assay. Two known and three novel CD4+ T cell epitopes derived from the gp 100/pmel17 and tyrosinase mefanocyte-associated antigens were confirmed or identified. Of major interest, we determined that freshly-isolated PBMC frequencies of Th1-type CD4+ T recognizing these peptides are frequently elevated in HLA-DR4+ melanoma patients (but not normal donors) that are currently disease-free as a result of therapeutic intervention. Epitope-specific CD4+ T cells from normal DR4+ donors could be induced, however, after in vitro stimulation with autologous dendritic cell pulsed with antigens (peptides or antigen-positive melanoma lysates) or infected with recombinant vaccinia virus encoding the relevant antigen. Peptide-reactive CD4+ T cells also recognized HLA-DR4+ melanoma cell lines that constitutively express the relevant antigen. Based on these data, these epitopes may serve as potent vaccine components to promote clinically-relevant Th1-type CD4+ T cell effector function in situ. (C) 2001 Cancer Research Campaign

MAGE-6 encodes HLA-DRbeta1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinoma

CD4+ T cells modulate the magnitude and durability of CTL responses in vivo and may serve as potent effector cells within the tumor microenvironment. The current study was undertaken to define novel epitopes from the broadly expressed tumor antigen MAGE-6 that are recognized by CD4+ T cells. We have combined the use of a HLA-DR4/peptide binding algorithm with the IFN-gamma enzyme-linked immunospot assay to identify four nonoverlapping sequences derived from the MAGE-6 protein that served as CD4+ T-cell epitopes in HLA-DR4+ donors. Strikingly, patients with active melanoma or renal cell carcinoma failed to secrete IFN-gamma in response to MAGE-6-derived epitopes, whereas both normal donors and cancer patients with no current evidence of disease were responsive, particularly after short-term in vitro stimulations with peptide-pulsed dendritic cells. Importantly, peptide-specific CD4+ T cells also recognized HLA-DRbeta1*0401+ tumor cells that constitutively expressed the MAGE-6 protein and autologous HLA-DRbeta1*0401+ dendritic cells transfected with MAGE-6 cDNA-elicited CD4+ T cells that reacted against individual peptide epitopes in vitro. These data suggest that MAGE-6-derived epitopes could serve as useful vaccine candidate components and may provide an immune-monitoring index of clinically important Th1-type immunity in patients with renal cell carcinoma or melanoma